or Try an Advanced Search...

    Inflammation Stocks List

    Symbol Grade Name % Change
    ICU F SeaStar Medical Holding Corporation -7.16
    OCUP F Ocuphire Pharma, Inc. -5.67
    QTRX F Quanterix Corporation -4.90
    CNTB D Connect Biopharma Holdings Limited -4.61
    EQ D Equillium, Inc. -4.49
    KOD D Kodiak Sciences Inc -3.77
    ARGX C argenx SE -3.19
    CTXR F Citius Pharmaceuticals, Inc. -3.10
    OCUL D Ocular Therapeutix, Inc. -3.04
    OMER D Omeros Corporation -3.02
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Medicine Biology Biopharmaceutical Ophthalmology Angiogenesis Biotechnology Cataracts Clinical Trial Diabetic Retinopathy Eye Immune System Immunology Immunotherapy Macular Degeneration Organ Systems Retina Retinopathy Skin Inflammation Urology Vascular Disease

    Related ETFs - A few ETFs which own one or more of the above listed Inflammation stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH C Market Vectors Pharmaceutical ETF 14.34
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.1
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.85
    View all Inflammation ETFs...
    Compare ETFs
    Compare EDEN to HDLB Compare EDEN to IGTR Compare IGTR to FTXH

        Inflammation Stocks Recent News

        Date Stock Title
        May 8 ARGX Argenx SE Q1 2024 Earnings Preview
        May 7 OCUL Ocular Therapeutix Inc Reports First Quarter 2024 Earnings
        May 7 ARGX argenx announces results of Annual General Meeting of Shareholders
        May 7 QTRX Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
        May 7 OCUL Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M
        May 7 QTRX Quanterix GAAP EPS of -$0.26 beats by $0.05, revenue of $32.1M beats by $0.6M
        May 7 OCUL Ocular Therapeutix™ Reports First Quarter 2024 Results
        May 7 QTRX Quanterix Releases Financial Results for the First Quarter of 2024
        May 7 EQ Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
        May 7 CNTB Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
        May 7 ARGX argenx: Innovation Over Losses In Autoimmune Arena
        May 7 ARGX argenx to Present at BofA Securities 2024 Health Care Conference
        May 7 OCUL Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
        May 6 OCUL Ocular Therapeutix Q1 2024 Earnings Preview
        May 6 QTRX Quanterix Q1 Earnings Preview
        May 6 OCUP Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
        May 6 OCUL Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
        May 3 OCUP Ocuphire Pharma to Present at the Aegis Virtual Conference
        May 3 OCUL Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
        May 2 KOD Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
        Related Industries: Biotechnology Conglomerates Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Biopharmaceutical Biology Immune System Immunology Medicine Ophthalmology Allergic Conjunctivitis Antibody Biotechnology Cataracts Cell Biology Clinical Development Clinical Trial Disease Hypertension Macular Degeneration Pain Pharmaceutical Products Skin Inflammation Wet Age Related Macular Degeneration
        Inflammation

        Inflammation is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.

        More about Inflammation
        Browse All Tags